Quantitative Muscle Mri Biomarkers in Duchenne Muscular Dystrophy: Cross-Sectional Correlations with Age and Functional Tests

References

• Ryder S , LeadleyRM, ArmstrongNet al. The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review. Orphanet. J. Rare Dis.12(1), 79 (2017).
   Google Scholar
• Venugopal V , PavlakisS. Duchenne muscular dystrophy.StatPearls LLC, Treasure Island, FL, USA (2018).
   Google Scholar
• Landfeldt E , ThompsonR, SejersenT, McMillanHJ, KirschnerJ, LochmullerH. Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis. Eur. J. Epidemiol.35(7), 643–653 (2020).
   PubMed Web of Science ®Google Scholar
• Goemans N , vanden Hauwe M, WilsonR, van ImpeA, KlingelsK, BuyseG. Ambulatory capacity and disease progression as measured by the 6-min-walk-distance in Duchenne muscular dystrophy subjects on daily corticosteroids. Neuromuscul. Disord.23(8), 618–623 (2013).
   PubMedGoogle Scholar
• Pane M , MazzoneES, SormaniMPet al. 6 minute walk test in Duchenne MD patients with different mutations: 12 month changes. PLoS ONE9(1), e83400 (2014).
   PubMed Web of Science ®Google Scholar
• Akima H , LottD, SenesacCet al. Relationships of thigh muscle contractile and non-contractile tissue with function, strength, and age in boys with Duchenne muscular dystrophy. Neuromuscul. Disord.22(1), 16–25 (2012).
   PubMed Web of Science ®Google Scholar
• Marden FA , ConnollyAM, SiegelMJ, RubinDA. Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging. Skeletal Radiol.34(3), 140–148 (2005).
   PubMedGoogle Scholar
• Mathur S , LottDJ, SenesacCet al. Age-related differences in lower-limb muscle cross-sectional area and torque production in boys with Duchenne muscular dystrophy. Arch. Phys. Med. Rehabil.91(7), 1051–1058 (2010).
   PubMedGoogle Scholar
• Mercuri E , PichiecchioA, AllsopJ, MessinaS, PaneM, MuntoniF. Muscle MRI in inherited neuromuscular disorders: past, present, and future. J. Magn. Reson. Imaging25(2), 433–440 (2007).
   PubMedGoogle Scholar
• Wren TA , BlumlS, Tseng-OngL, GilsanzV. Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. AJR Am. J. Roentgenol.190(1), W8–W12 (2008).
   PubMed Web of Science ®Google Scholar
• Guiraud S , DaviesKE. Pharmacological advances for treatment in Duchenne muscular dystrophy. Curr. Opin. Pharmacol.34, 36–48 (2017).
   PubMed Web of Science ®Google Scholar
• Hollingsworth KG , GarroodP, EagleM, BushbyK, StraubV. Magnetic resonance imaging in Duchenne muscular dystrophy: longitudinal assessment of natural history over 18 months. Muscle Nerve48(4), 586–588 (2013).
   PubMedGoogle Scholar
• Ricotti V , EvansMR, SinclairCDet al. Upper limb evaluation in duchenne muscular dystrophy: fat-water quantification by MRI, muscle force and function define endpoints for clinical trials. PLoS ONE11(9), e0162542 (2016).
   PubMedGoogle Scholar
• Arpan I , ForbesSC, LottDJet al. T2 mapping provides multiple approaches for the characterization of muscle involvement in neuromuscular diseases: a cross-sectional study of lower leg muscles in 5–15-year-old boys with Duchenne muscular dystrophy. NMR Biomed.26(3), 320–328 (2013).
   PubMedGoogle Scholar
• Barnard AM , WillcocksRJ, FinangerELet al. Skeletal muscle magnetic resonance biomarkers correlate with function and sentinel events in Duchenne muscular dystrophy. PLoS ONE13(3), e0194283 (2018).
   PubMed Web of Science ®Google Scholar
• Gaeta M , MessinaS, MiletoAet al. Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments. Preliminary experience. Skeletal Radiol.41(8), 955–961 (2012).
   PubMedGoogle Scholar
• Godi C , AmbrosiA, NicastroFet al. Longitudinal MRI quantification of muscle degeneration in Duchenne muscular dystrophy. Ann. Clin. Transl. Neurol.3(8), 607–622 (2016).
   PubMedGoogle Scholar
• Mankodi A , BishopCA, AuhS, NewbouldRD, FischbeckKH, JaniczekRL. Quantifying disease activity in fatty-infiltrated skeletal muscle by IDEAL-CPMG in Duchenne muscular dystrophy. Neuromuscul. Disord.26(10), 650–658 (2016).
   PubMedGoogle Scholar
• Schmidt S , HafnerP, KleinAet al. Timed function tests, motor function measure, and quantitative thigh muscle MRI in ambulant children with Duchenne muscular dystrophy: a cross-sectional analysis. Neuromuscul. Disord.28(1), 16–23 (2018).
   PubMedGoogle Scholar
• Ropars J , GravotF, BenSalem D, RousseauF, BrochardS, PonsC. Muscle MRI: a biomarker of disease severity in Duchenne muscular dystrophy? A systematic review. Neurology94(3), 117–133 (2020).
   PubMedGoogle Scholar
• Barnard AM , WillcocksRJ, TriplettWTet al. MR biomarkers predict clinical function in Duchenne muscular dystrophy. Neurology94(9), e897–e909 (2020).
   PubMed Web of Science ®Google Scholar
• Naarding KJ , ReyngoudtH, van ZwetEWet al. MRI vastus lateralis fat fraction predicts loss of ambulation in Duchenne muscular dystrophy. Neurology94(13), e1386–e1394 (2020).
   PubMedGoogle Scholar
• Nagy S , SchadelinS, HafnerPet al. Longitudinal reliability of outcome measures in patients with Duchenne muscular dystrophy. Muscle Nerve61(1), 63–68 (2020).
   PubMedGoogle Scholar
• Wagner KR , Abdel-HamidHZ, MahJKet al. Randomized Phase II trial and open-label extension of domagrozumab in Duchenne muscular dystrophy. Neuromuscul. Disord.30(6), 492–502 (2020).
   PubMed Web of Science ®Google Scholar
• Cai W , ChenS, ZhangD. Fast and robust fuzzy c-means clustering algorithms incorporating local information for image segmentation. Pattern Recognition40(3), 825–838 (2007).
   Web of Science ®Google Scholar
• Positano V , ChristiansenT, SantarelliMF, RinggaardS, LandiniL, GastaldelliA. Accurate segmentation of subcutaneous and intermuscular adipose tissue from MR images of the thigh. J. Magn. Reson. Imaging29(3), 677–684 (2009).
   PubMedGoogle Scholar
• Xu C , PrinceJL. Snakes, shapes, and gradient vector flow. IEEE Trans. Image Process7(3), 359–369 (1998).
   PubMed Web of Science ®Google Scholar
• Forbes SC , WillcocksRJ, TriplettWTet al. Magnetic resonance imaging and spectroscopy assessment of lower extremity skeletal muscles in boys with Duchenne muscular dystrophy: a multicenter cross sectional study. PLoS ONE9(9), e106435 (2014).
   PubMedGoogle Scholar
• Willcocks RJ , ArpanIA, ForbesSCet al. Longitudinal measurements of MRI-T2 in boys with Duchenne muscular dystrophy: effects of age and disease progression. Neuromuscul. Disord.24(5), 393–401 (2014).
   PubMed Web of Science ®Google Scholar
• Wokke BH , vanden Bergen JC, VersluisMJet al. Quantitative MRI and strength measurements in the assessment of muscle quality in Duchenne muscular dystrophy. Neuromuscul. Disord.24(5), 409–416 (2014).
   PubMed Web of Science ®Google Scholar
• Bonati U , HafnerP, SchadelinSet al. Quantitative muscle MRI: a powerful surrogate outcome measure in Duchenne muscular dystrophy. Neuromuscul. Disord.25(9), 679–685 (2015).
   PubMed Web of Science ®Google Scholar
• Kim HK , SeraiS, LindquistDet al. Quantitative skeletal muscle MRI: part 2, MR spectroscopy and T2 relaxation time mapping-comparison between boys with Duchenne muscular dystrophy and healthy boys. AJR Am. J. Roentgenol.205(2), W216–W223 (2015).
   PubMed Web of Science ®Google Scholar
• Kim HK , LaorT, HornPS, RacadioJM, WongB, DardzinskiBJ. T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments. Radiology255(3), 899–908 (2010).
   PubMedGoogle Scholar
• Johnston JH , KimHK, MerrowACet al. Quantitative skeletal muscle MRI: part 1, derived T2 fat map in differentiation between boys with Duchenne muscular dystrophy and healthy boys. AJR Am. J. Roentgenol.205(2), W207–W215 (2015).
   PubMedGoogle Scholar
• Willcocks RJ , RooneyWD, TriplettWTet al. Multicenter prospective longitudinal study of magnetic resonance biomarkers in a large duchenne muscular dystrophy cohort. Ann. Neurol.79(4), 535–547 (2016).
   PubMed Web of Science ®Google Scholar
• Arpan I , WillcocksRJ, ForbesSCet al. Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS. Neurology83(11), 974–980 (2014).
   PubMedGoogle Scholar
• Wagner KR , Abdel-HamidHZ, MahJKet al. Corrigendum to “Randomized Phase II trial and open-label extension of domagrozumab in Duchenne muscular dystrophy” [Neuromuscular Disorders, Vol. 30 (6) 2020, 492–502]. Neuromuscul. Disord. doi:10.1016/j.nmd.2021.01.001 (2021) ( Epub ahead of print).
   PubMedGoogle Scholar